Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06249555
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2024-01-24
Brief Title:
VOICE-Early Response to Vedolizumab and Ustekinumab in Participants With Crohns Disease A Prospective Observational Study
Sponsor:
Organization:
Alimentiv Inc